Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma
about
The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancerAdjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinomaTumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival.Merkel Cell Carcinoma Therapeutic Update.Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.Merkel cell polyomavirus infection and Merkel cell carcinoma.Cancer treatment and the KIR-HLA system: an overview.How does the Merkel polyomavirus lead to a lethal cancer? Many answers, many questions, and a new mouse model.Immunotherapy with imiquimod and interferon alfa for metastasized Merkel cell carcinoma.Merkel cell carcinoma in the age of immunotherapy: Facts and hopes.Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.Viral Oncology: Molecular Biology and Pathogenesis.The anti-PD-1 era - an opportunity to enhance radiotherapy for patients with bladder cancer.Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma.Avelumab and other recent advances in Merkel cell carcinoma.Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus.Prognostic factors and immunobiologic insights into Merkel cell carcinoma.Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future OptionsAcquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
P2860
Q28083883-6C8D2210-B44E-4B6C-8728-6E76AF582576Q31104346-8F0D3F8A-DE99-4741-9F25-C6EE541C3501Q33720183-77924AD3-B778-4B09-8E58-556BA9833D67Q38721030-E17DE87C-0437-4371-A6EB-AD290B02EFFEQ38855025-2B9B7F7B-12E8-4A6A-B4B3-2E1F789CE6B3Q38887303-0CD46A8F-5C6D-4271-A870-6214D2E1A9A8Q38926910-91091B86-344D-4DE8-A321-BFE215EA1AEFQ39131056-CFB5AF50-ED14-49BB-8E21-74A0892419D9Q39776316-1A080D33-7180-407F-BCFB-3B24A2DEC725Q40289983-A2C826D6-38E5-42DD-813E-9E7F0CB3BEE6Q47348356-00F4B38B-EB3F-4C50-B7DA-90D04C904F37Q47571383-44EE7969-0EE4-44AE-AFAA-1AE708F2BFF5Q47571734-9744B4B5-F711-4627-8796-E46669B9382BQ47580489-43F1884F-F6B7-46DE-8CE5-232996F03193Q47584286-5C445BB3-0689-49EE-8DB1-4DA81DE5BFE9Q47915808-667D9C71-72D8-49AC-98B0-22B4B149FB29Q48375750-42F278FE-FF34-41A5-9E48-269E23440FD4Q52804789-8DE12110-0F41-4F3B-B44A-890A2EE1F11AQ52939164-31A9E75F-79F8-4AEF-8C3D-D3F23ACE2645Q56890107-CEC7449B-A309-4030-A72D-2F37F7CC10DFQ58700455-88B592D9-5092-4DD8-B083-247CD87C1877
P2860
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma
@en
type
label
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma
@en
prefLabel
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma
@en
P2093
P2860
P50
P1476
Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma
@en
P2093
Andrew Tegeder
Christoph Willmes
David Schrama
Hideki Nakajima
James S Hardwick
Jayasri G Iyer
Jürgen C Becker
Kotaro Nagase
Margaret Madeleine
Mary L Disis
P2860
P304
P356
10.1158/2326-6066.CIR-14-0005
P577
2014-08-12T00:00:00Z